OmniStar Financial Group’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,200
Closed -$873K 150
2024
Q2
$873K Buy
8,200
+10
+0.1% +$959 0.79% 35
2024
Q1
$796K Buy
+8,190
New +$720K 0.73% 39
2022
Q4
Sell
-6,860
Closed -$251K 108
2022
Q3
$251K Buy
6,860
+170
+3% +$7.57K 0.3% 95
2022
Q2
$285K Buy
6,690
+60
+0.9% +$2.86K 0.32% 94
2022
Q1
$356K Buy
6,630
+2,380
+56% +$139K 0.35% 87
2021
Q4
$306K Buy
4,250
+40
+1% +$2.51K 0.31% 100
2021
Q3
$239K Sell
4,210
-450
-10% -$27.4K 0.28% 100
2021
Q2
$303K Sell
4,660
-190
-4% -$12K 0.38% 82
2021
Q1
$289K Sell
4,850
-12,130
-71% -$661K 0.37% 88
2020
Q4
$802K Sell
16,980
-170
-1% -$7.15K 0.56% 61
2020
Q3
$569K Buy
+17,150
New +$591K 0.43% 74
2020
Q2
Sell
-1,940
Closed -$47K 232
2020
Q1
$47K Buy
+1,940
New +$55.9K 0.05% 141
2019
Q4
Sell
-52,330
Closed -$1.21M 115
2019
Q3
$1.21M Sell
52,330
-5,670
-10% -$119K 1.06% 36
2019
Q2
$1.09M Buy
58,000
+80
+0.1% +$1.52K 0.98% 44
2019
Q1
$1.04M Buy
+57,920
New +$966K 0.91% 47

Other funds holding LRCX

OmniStar Financial Group's LRCX Position: Q3 2024 in Review

OmniStar Financial Group sold out of Lam Research (LRCX) in Q3 2024, closing a stake of 8,200 shares — an estimated $873K sold.

OmniStar Financial Group first reported a position in LRCX in Q1 2019 and held it in 15 quarters. The position peaked at $1.21M in Q3 2019. 1,464 funds tracked by Wall St. Rank hold LRCX as of Q3 2024.

  • OmniStar Financial Group reported no remaining Lam Research position as of Q3 2024 after selling out during the quarter.
  • OmniStar Financial Group sold 8,200 Lam Research shares in Q3 2024, an estimated $873K.
  • OmniStar Financial Group first reported a position in Lam Research in Q1 2019 and held it in 15 quarters.
  • OmniStar Financial Group's Lam Research position peaked at $1.21M in Q3 2019.
  • 1,464 funds tracked by Wall St. Rank held Lam Research as of Q3 2024.

Based on OmniStar Financial Group's 13F filing for Q3 2024, filed 17 Oct 2024.